news roundup
Updated employee announcements, business news, awards, and recognition in the industry today.
| Advertisement
Debunking the Myths of Risk-Based Monitoring for a New Approach to Quality Management
On Demand
 Learn more |
Genstar Capital is pleased to announce the acquisition of CRF Health. Through this acquisition, CRF Health will also be combined with Bracket, a provider of software and technology-enabled solutions.
Leader of one longtime CRO discusses the marked changes in clinical trial practice from past to present—and the company's unique focus.
Jill Wechsler details the continued rise of incorporating the "patient experience" in drug development measures.
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
The potential for innovative gene therapies to treat and even cure a range of serious diseases is prompting FDA to ramp up support for developing and testing new products efficiently and effectively.
A look at home and dosing site considerations.
|
|
Blog Posts
In this interview, Linda Rawlings, VP of Neurodegenerative Development at Synteract, elaborates on addressing the challenges of neurodegenerative disease clinical trials.
The question is, how much attention should be paid to historical recruitment figures if the team only reviews the data from one (or two) similar studies?
|
|
RBM
An RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.
|
|
|
CluePoints has launched the "CluePoints RBM and ICH E6 (R2) Starter Pack" to help small and medium-sized enterprises achieve regulatory compliance through a "risk-based" approach.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
